12min chapter

The Fellow on Call: The Heme/Onc Podcast cover image

Episode 096: Treatment of CLL

The Fellow on Call: The Heme/Onc Podcast

CHAPTER

Advancements in CLL Treatment

This chapter explores the evolving landscape of Chronic Lymphocytic Leukemia (CLL) therapies, particularly focusing on the impact of BTK inhibitors and the comparison of obinutuzumab versus rituximab. It highlights the significance of recent trials, treatment duration, and the role of venetoclax, while addressing patient-specific considerations in treatment choices.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode